Removal of Aβ Oligomers from the Blood: A Potential Therapeutic System for Alzheimer’s Disease

Código QR

Removal of Aβ Oligomers from the Blood: A Potential Therapeutic System for Alzheimer’s Disease

Yuta Saito, 1–3 Miwa Sakata, 3 Moe Kobayakawa, 3 Hiroshi Kawachi, 4 Kazunori Kawaguchi, 3 Yoshiyuki Hiki, 3 Masao Kato, 1 Mayuko Mori, 1, 3 Midori Hasegawa, 1 Norimi Ohashi, 4 Yukio Yuzawa, 1 Nobuya Kitaguchi 3 1Department of Nephrology, School of Medicine, Fujita Health University, Toyoa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Saito Y, Sakata M, Kobayakawa M, Kawachi H, Kawaguchi K, Hiki Y, Kato M, Mori M, Hasegawa M, Ohashi N, Yuzawa Y, Kitaguchi N
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	aβ amyloid beta oligomer alzheimer’s disease blood purification membrane separation Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/06a560a2c9e14525a9e3896d39fab4c2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers
por: Sun LP, et al.
Publicado: (2018)

A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles
por: Xing Y, et al.
Publicado: (2017)

Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report
por: Kitaguchi N, et al.
Publicado: (2018)

Multifunctional Superparamagnetic Iron Oxide Nanoparticles Conjugated with Aβ Oligomer-Specific scFv Antibody and Class A Scavenger Receptor Activator Show Early Diagnostic Potentials for Alzheimer’s Disease
por: Liu XG, et al.
Publicado: (2020)

Mechanism of Amyloid Gel Formation by Several Short Amyloidogenic Peptides
por: Oxana V. Galzitskaya, et al.
Publicado: (2021)

Modeling the neuron as a nanocommunication system to identify spatiotemporal molecular events in neurodegenerative disease
por: Banerjee A, et al.
Publicado: (2018)

Alzheimer disease: 100 years later
por: Puglielli MD,Luigi, et al.
Publicado: (2001)

Aβ Influx into the Blood Evoked by Different Blood Aβ Removal Systems: A Potential Therapy for Alzheimer’s Disease
por: Kitaguchi N, et al.
Publicado: (2021)

Effect of Curcumin on Beta-Amyloid Plasma Level in Alzheimer Disease: A Systematic Review and Meta-analysis
por: Shima Mehrabadi, et al.
Publicado: (2021)

Histidines 13 and 14 in the Aβ sequence are targets for inhibition of Alzheimer's disease Aβ ion channel and cytotoxicity
por: DÍAZ,JUAN CARLOS, et al.
Publicado: (2006)

Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis
por: Raquel Sanchez-Varo, et al.
Publicado: (2021)

Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease
por: Zhang YY, et al.
Publicado: (2013)

Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020)

Long noncoding RNAs and Alzheimer's disease
por: Luo Q, et al.
Publicado: (2016)

APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
por: I. K. Malashenkova, et al.
Publicado: (2018)

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
por: Pyun JM, et al.
Publicado: (2021)

Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus
por: Jeong HR, et al.
Publicado: (2015)

Phenolic composition, antioxidant activity, anticholinesterase potential and modulatory effects of aqueous extracts of some seaweeds on β-amyloid aggregation and disaggregation
por: Tosin A. Olasehinde, et al.
Publicado: (2019)

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
por: Tiwari S, et al.
Publicado: (2019)

Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
por: Vyronia Vassilakopoulou, et al.
Publicado: (2021)

Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation
por: Kanubaddi KR, et al.
Publicado: (2018)

SYNTHESIS OF 3,3'''-DIOCTYLTETRATHIOPHENE OLIGOMER
por: MARTINEZ,FRANCISCO, et al.
Publicado: (2000)

Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
por: Giacomo Stroffolini, et al.
Publicado: (2021)

OLIGOMER CHAIN LENGTH EFFECT ON THE NUCLEATION AND GROWTH MECHANISMS (NGM) OF POLYTHIOPHENE
por: DEL VALLE,M. ANGÉLICA, et al.
Publicado: (2009)

Perspectivas en la prevención y tratamiento farmacológico de la enfermedad de Alzheimer
por: Archibaldo Donoso,S, et al.
Publicado: (2009)

Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process
por: Javdani N, et al.
Publicado: (2019)

Isoorientin Inhibits Amyloid β<sub>25–35</sub>-Induced Neuronal Inflammation in BV2 Cells by Blocking the NF-κB Signaling Pathway
por: Buyun Kim, et al.
Publicado: (2021)

CD4+ effector T cells accelerate Alzheimer’s disease in mice
por: Jatin Machhi, et al.
Publicado: (2021)

Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
por: Haiyan Liu, et al.
Publicado: (2021)

Study of Histopathological Lesions in CA1 of the Hippocampus after Injection of Beta-Amyloid in a Rat Model of Alzheimer’s Disease
por: SM Hoseini,, et al.
Publicado: (2012)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
por: Guimei Zhang, et al.
Publicado: (2021)

Extensive frontal focused ultrasound mediated blood–brain barrier opening for the treatment of Alzheimer’s disease: a proof-of-concept study
por: So Hee Park, et al.
Publicado: (2021)

Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer’s disease treatment
por: Kuo YC, et al.
Publicado: (2017)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)

The Protective Effect of Ubiquinone against the Amyloid Peptide in Endothelial Cells Is Isoprenoid Chain Length-Dependent
por: Javier Frontiñán-Rubio, et al.
Publicado: (2021)

Attenuative Effects of Fluoxetine and <i>Triticum aestivum</i> against Aluminum-Induced Alzheimer’s Disease in Rats: The Possible Consequences on Hepatotoxicity and Nephrotoxicity
por: Karema Abu-Elfotuh, et al.
Publicado: (2021)

Effect of Beta asarone on concentration of TNF-α in a rat model of Alzheimer’s disease
por: Golshid Saki, et al.
Publicado: (2021)

Amyloid-β 25-35 Induces Neurotoxicity through the Up-Regulation of Astrocytic System X<sub>c</sub><sup>−</sup>
por: Veronica D’Ezio, et al.
Publicado: (2021)

Federated Morphometry Feature Selection for Hippocampal Morphometry Associated Beta-Amyloid and Tau Pathology
por: Jianfeng Wu, et al.
Publicado: (2021)

Microbiota-Derived β-Amyloid-like Peptides Trigger Alzheimer’s Disease-Related Pathways in the SH-SY5Y Neural Cell Line
por: Aitor Blanco-Míguez, et al.
Publicado: (2021)